KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASRT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Assertio Therapeutics stock price on Thursday moving between $0.739 and $0.86
(Updated on Apr 25, 2024)

Sell candidate since Apr 24, 2024 Loss -9.30% PDF

The Assertio Therapeutics stock price fell by -9.30% on the last day (Thursday, 25th Apr 2024) from $0.87 to $0.785. During the last trading day the stock fluctuated 16.63% from a day low at $0.739 to a day high of $0.86. The price has fallen in 7 of the last 10 days and is down by -11.02% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $2.28 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.759 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.97% during the next 3 months and, with a 90% probability hold a price between $0.80 and $1.24 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASRT Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 4.12%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Assertio Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.82 and $0.94. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Assertio Therapeutics stock

Assertio Therapeutics finds support from accumulated volume at $0.785 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.123 between high and low, or 16.63%. For the last week, the stock has had daily average volatility of 10.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ASRT) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Assertio Therapeutics Inc. to open at $0.795, and during the day (based on 14 day Average True Range), to move between $0.719 and $0.85, which gives a possible trading interval of +/-$0.0664 (+/-8.45%) up or down from last closing price. If Assertio Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 16.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.785 (0.01%) than the resistance at $0.82 (4.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Assertio Therapeutics Inc. stock A Buy?

The Assertio Therapeutics stock holds several negative signals and despite the positive trend, we believe Assertio Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.634 Sell Candidate Unchanged

Predicted Opening Price for Assertio Therapeutics Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.795 ( 1.26%) $0.785

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASRT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.92 16.90 %
R2 0.87 10.92 %
R1 0.84 7.23 %
Current price: 0.785
Support S1 0.748 -4.72 %
S2 0.719 -8.41 %
S3 0.672 -14.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.91 16.13 %
R2 0.88 12.41 %
R1 0.82 4.84 %
Current price 0.785
Support S1 0.785 -0.0127%
S2 0.780 -0.650%
S3 0.773 -1.54%

FAQ

What is the symbol for Assertio Therapeutics Stock and on which exchange is it traded?
The symbol for Assertio Therapeutics is ASRT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Assertio Therapeutics Stock?
The Assertio Therapeutics stock holds several negative signals and despite the positive trend, we believe Assertio Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Assertio Therapeutics Stock?
Assertio Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Assertio Therapeutics Stock.

What's the current price of Assertio Therapeutics Stock?
As of the end of day on the Apr 25, 2024, the price of an Assertio Therapeutics (ASRT) share was $0.785.

What is the 52-week high and low for Assertio Therapeutics Stock?
The 52-week high for Assertio Therapeutics Stock is $8.01 and the 52-week low is $0.739.

What is the market capitalization of Assertio Therapeutics Stock?
As of the Apr 25, 2024, the market capitalization of Assertio Therapeutics is 74.68M.

When is the next earnings date for Assertio Therapeutics?
The upcoming earnings date for Assertio Therapeutics is May 14, 2024.
Click to get the best stock tips daily for free!

About Assertio Therapeutics Inc.

Assertio Therapeutics Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, ... ASRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT